| 发明名称 |
Use of prodrugs for ocular intravitreous administration |
| 摘要 |
<p>Use of a composition comprising at least one prodrug of a steroid, preferably of a corticosteroid, for the preparation of an ophthalmic composition intended for the treatment of an ocular condition or disease of a human being or an animal.</p> |
| 申请公布号 |
EP2322183(B1) |
申请公布日期 |
2014.10.22 |
| 申请号 |
EP20100177375 |
申请日期 |
2006.06.01 |
| 申请人 |
SANTEN SAS |
发明人 |
LAMBERT, GRÉGORY;RABINOVICH-GUILATT, LAURA |
| 分类号 |
A61K31/573;A61K47/48;A61P27/00 |
主分类号 |
A61K31/573 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
